Navigation Links
Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures
Date:12/2/2009

NEW YORK, Dec. 2 /PRNewswire-USNewswire/ -- Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugural Partnering for Cures meeting.

FasterCures, the Washington-based center of the Milken Institute, convened Partnering for Cures to facilitate multi-sector collaborations needed to turn a scientific discovery into an accessible therapy. This effort unites the power of philanthropy, passion of nonprofit disease organizations, and the expertise of biotechnology and pharmaceutical companies.

"With all the financial and human capital flowing through America's medical system, there are still too many diseases for which there are no cures or effective treatments. We want to help change that," said Margaret Anderson, Executive Director of FasterCures. "One of our goals for this effort is to catalyze a more effective and efficient medical research enterprise through more strategic and timely allocation of critical resources."

Partnering for Cures highlighted best practices in the conduct and management of medical research and outcomes-oriented approaches that could streamline the process. It provided participants with a unique opportunity to learn first-hand from cure entrepreneurs, nonprofit leaders who are producing dramatic results for patients, from cystic fibrosis and multiple myeloma to malaria and HIV.

"We believe the incentives of all the stakeholders in medical research can be better aligned to produce the result all are working towards - value and benefit for patients. This effort helps facilitate this alignment," added Anderson.

The meeting featured more than 80 of the most forward-thinking leaders spotlighting solutions to decades-long challenges facing the medical research system, 42 medical research foundations presented their research portfolio and development strategies, and a partnering system that facilitated one-on-one connections between participants.

About FasterCures

FasterCures/The Center for Accelerating Medical Solutions is committed to saving lives by saving time in the research, discovery and development of new treatments for deadly and debilitating diseases. FasterCures, a center of the Milken Institute, is nonpartisan, nonprofit and independent of interest groups. For more information, visit www.fastercures.org.

Video highlights and session summaries will be available at www.partneringforcures.org.

SOURCE FasterCures


'/>"/>
SOURCE FasterCures
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Gamida Cell Announces Feasibility Study With Weill Cornell Medical College
2. New Jerseys Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development
3. PacsDrive Announces Low Cost Medical Imaging Storage Service, Seeks to Alter Status Quo in Health Care IT
4. Aethlon Medical to Present at LD MICRO Conference on December 3, 2009
5. China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia
6. ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ
7. Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence
8. Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers
9. Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases
10. Entest BioMedical Files 3rd Patent Application for COPD Stem Cell Treatment
11. BioMS Medical Announces Third Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... , Jan. 20, 2017 Bioptix, Inc. ... "Company"), announced that on January 14, 2017 the Board ... which the Company will terminate certain employees associated with ... Inc.  The Company commenced terminations on January 16, 2017 ... days.  The Company may pay severance benefits in certain ...
(Date:1/20/2017)... -- Ginkgo Bioworks, the organism company, announced today ... synthesis and assembly of DNA. The acquisition will ... DNA into Ginkgo,s automated organism engineering foundries, enabling ... new organism designs for application across a wide ... to significantly increase the world,s capacity to cost-effectively ...
(Date:1/19/2017)... LOUISVILLE, Ky. and HOUSTON ... Prenatal Inc. ("NX Prenatal") today announced the formation ... brings together leading clinicians and industry veterans who ... the company as it accelerates development of its ... positioned to provide medical, clinical and strategic guidance ...
(Date:1/19/2017)... Md. and GAITHERSBURG, Md. ... (NYSE MKT: PIP) and Altimmune, Inc., a privately-held ... signing of a definitive agreement for the merger ... Altimmune,s current investors include Novartis Venture Fund, HealthCap, ... will be a fully-integrated and diversified immunotherapeutics company ...
Breaking Biology Technology:
(Date:1/11/2017)... , Jan. 11, 2017 Intoxalock, a ... with the release of its patent-pending calibration device. With ... reliably perform calibrations, securely upload data logs and process ... the customer. "Fighting drunk driving through the ... the public at large, but also for the customer ...
(Date:1/6/2017)... LA JOLLA, Calif. , Jan. 6, 2017 ... Phase 1 safety studies in healthy volunteers of ... CM4620, intended to treat acute pancreatitis. ... pancreas, is typically a mild disorder, but can ... to organ failure and sepsis, where extended hospital ...
(Date:1/6/2017)... 2017  Delta ID Inc., a leader in consumer-grade ... automotive at CESĀ® 2017. Delta ID has collaborated with ... the use of iris scanning as a secure, reliable ... in a car, and as a way to elevate ... Delta ID and Gentex will demonstrate (booth #7326 ...
Breaking Biology News(10 mins):